Diary - News
All news Erytech announces granting of new patent in the United States
ERYTECH (Euronext Paris: FR0011471135 – ERYP), the French biopharmaceutical company that develops innovative ‘tumor starvation’ treatments for acute leukemia and other oncology indications with unmet medical needs, announces the granting of a new patent in the field of asparaginase in the United States.
Read the press release
